On November 5, 2026, CITIC Securities Company Limited sold shares of SINOPHARM (01099) on the SEHK open market in an on-exchange active trade matched on the exchange, constituting a direct secondary-market dealing.
Prior to the disposal, CITIC Securities Company Limited’s long position in SINOPHARM was 134.30 million shares, representing 10.01%; following the disposal, the holding changed to 133.84 million shares, with the long position ratio falling to 9.97%.